Developer docs
API playgroundTry for free, no card

Search company profiles

Hemas Holdings

Full company profile

uuid00069xm

Namestring
Hemas Holdings
Legal namestring
Hemas Holdings PLC
Websiteurl
hemas.com
Company typeenum
Public
Founded yearint
1948
Descriptiontext

Hemas Holdings PLC is a publicly listed Sri Lankan conglomerate (Colombo Stock Exchange ticker: HHL) operating across three core sectors: Consumer Brands, Healthcare, and Mobility. The Consumer Brands portfolio comprises 12+ sub-brands spanning baby care (Baby Cheramy, 1962), oral care (Clogard, 1992), laundry (Diva, 2003), feminine hygiene (Fems), hair care (Kumarika), men's grooming (Gold), beauty (Velvet, Vivya, Paris, Goya), and learning/stationery (Atlas, acquired 2018 and wholly owned since 2023). Manufacturing is concentrated at the Dankotuwa industrial complex and Homagama pharmaceutical plant, with proprietary consumer technologies including the Golden Trice Blend (heirloom rice skincare), Fit to Body (sanitary napkins), and Triple Action detergent stack.

The Healthcare segment covers pharmaceutical distribution and WHO-GMP compliant manufacturing through Morison Limited (70+ year heritage brands including Gripe Mixture, Lacto Calamine, Valmelix), plus Hemas Hospitals operating two state-of-the-art facilities in Wattala (with cardiac catheterization and mammography) and the newly opened Thalawathugoda site, holding ACHSI international accreditation. Revenue from this segment reached Rs. 33.6 billion in FY2024 H1 with Rs. 2.8 billion operating profit.

The Mobility segment acts as a captive channel partner and General Sales Agent representing international principals: Forbes Air Services has been Emirates' GSA in Sri Lanka for 30+ years managing 28 weekly flights, while Hemas Maritime/Evergreen Shipping Agency Lanka, Mazu Shipping, and FAR Shipping Agency (ISO 9001:2015) collectively service 17 container services and feeder routes across the Indian Subcontinent, Far East, and Bay of Bengal. Total H1 FY2024 group revenue was Rs. 54.4 billion with Rs. 5.0 billion operating profit; Hemas sells through a horizontally segmented model across traditional trade, modern trade, pharmacy, hospital, and GSA channels, with recent digital additions including the Fio period-tracking app, Hair Buddy e-commerce brand, and Baby Cheramy Diaper Helpdesk generative AI chatbot.

Short descriptiontext

Hemas Holdings PLC is a publicly listed Sri Lankan conglomerate (CSE: HHL) operating across Consumer Brands (FMCG including Baby Cheramy, Clogard, Diva, Fems, Kumarika, Atlas), Healthcare (Morison pharmaceuticals, Hemas Hospitals), and Mobility (GSA for Emirates and Evergreen shipping), serving households, patients, and international principals across Sri Lanka and selected South Asian markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersColombo, Sri Lanka
HQ citystring
Colombo
HQ countrystring
Sri Lanka
HQ regionstring
Asia
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
FMCG manufacturing, personal care products, pharmaceutical distribution, healthcare services, logistics agency
Industry2 codes
1Pharmaceutical & Life Sciences Warehousing (GDP-Compliant)
CodeTLAIACADPrimaryYes
2Laundry & Textile Care Chemicals & Supplies Distribution
CodeCRAOAGAIPrimaryNo
NAICS code1 code
  • General Warehousing and Storage493110
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Diversified Conglomerate (FMCG, Healthcare, Mobility)
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Consumer Brands
TypeOne Time License
Description

FMCG products including home care, personal care, feminine hygiene, baby care, oral care, hair care, and stationery/learning products. Revenue generated through sale of branded consumer goods across Sri Lanka and select international markets (Bangladesh, Nepal).

hemas.com
2Healthcare - Pharmaceuticals
TypeTransaction Fee
Description

Pharmaceutical distribution and manufacturing. Distribution business holds market-leading position. Manufacturing includes Morison branded OTC products and prescription medications. Sector reported Rs. 33.6 billion cumulative revenue with Rs. 2.8 billion operating profit.

hemas.com
3Healthcare - Hospitals
TypeSubscription Recurring
Description

Private hospital services including inpatient admissions, outpatient volumes, and medical screenings. Hemas Hospitals includes facilities in Wattala and Thalawathugoda. Cardiac catheterization services added recently.

hemas.com
4Mobility - Aviation
TypeTransaction Fee
Description

Forbes Air Services operates as GSA for Emirates Airline for over 30 years. Supervises 28 weekly flights, managing passenger sales, cargo, pricing, retail services, and contact center operations.

hemas.com
5Mobility - Maritime
TypeTransaction Fee
Description

Evergreen Shipping Agency Lanka (6th largest container shipping line globally), Hemas Maritime, Mazu Shipping, and FAR Shipping Agency provide shipping agency services, logistics, and maritime solutions. Maritime sector experienced positive boost in volume and freight rates.

hemas.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 29 records shown
1Baby Cheramy Peach Range
Description

Original range of mild baby care products including soap, cream, cologne, shampoo and baby oil.

hemas.com
+28 more records
Core offering1 text field

Hemas Holdings PLC is a diversified Sri Lankan conglomerate that manufactures and distributes fast-moving consumer goods (FMCG) including baby care, personal care, oral care, feminine hygiene, hair care, and home care products under brands such as Baby Cheramy, Clogard, Diva, Fems, Kumarika, and Velvet. The group also operates Hemas Hospitals, distributes and manufactures pharmaceuticals through Hemas Pharmaceuticals and Morison Limited, and provides aviation and maritime logistics services as General Sales Agent (GSA) for Emirates Airline and as shipping agent for Evergreen Line and FAR Shipping.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduced water intensity by 11.8% to 1.5 m³ per rupee million in revenue
+4 more records
Product overview1 text field

Hemas Holdings is a diversified Sri Lankan conglomerate operating three core business segments: Consumer Brands (home and personal care, baby care, beauty, oral care, hair care, feminine hygiene, pharmaceuticals, and learning/stationery products), Healthcare (hospitals, pharmaceutical distribution and manufacturing), and Mobility (maritime and aviation logistics). The Consumer Brands portfolio comprises multiple sub-brands including Baby Cheramy, Clogard, Dandex, Diva, Fems, Goya, Kumarika, Velvet, Vivya, Paris, Gold, Morison, and Atlas. Healthcare includes Hemas Hospitals, Hemas Pharmaceuticals, and Morison pharmaceutical manufacturing. Mobility operates through Forbes Air Services, Evergreen Shipping Agency, Far Shipping Agency, and Mazu Shipping.

Product and service5 records
1Baby Cheramy
CategoryBaby Care FMCG
Description

Sri Lanka's leading baby care brand with 60-year heritage, offering toiletries, accessories, and skincare products for infants including Peach, Floral, Herbal, and Nil Manel ranges.

2Clogard
CategoryOral Care FMCG
Description

Oral care brand offering toothpastes (Original, Natural Salt, Pancha Shakthi, Chooty for children), toothbrushes, and mouthwash for complete family dental care.

3Diva
CategoryHome Care FMCG
Description

Flagship laundry brand offering detergent powder with Triple Action technology (Stain Fighter, Perfume Boost, Optical Brightener), liquid detergent, PODS, and Power range products.

4Fems
CategoryFeminine Hygiene FMCG
Description

Feminine hygiene brand offering sanitary napkins including Drytex Wings, Cotton Feel Wings, Superior Heavy Flow, and affordable Fems Aya line with Fit to Body technology.

5Kumarika
Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-30
Description

Service provider for safe collection and recycling of sanitary napkins under the Purple Bin Project. Encare manages Sri Lanka's largest centralized clinical waste management facility, approved by Central Environmental Authority. Collected sanitary napkins are recycled into eco-friendly bricks for sustainable building materials.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-04
Description

Hemas Consumer Brands and USJ forged landmark partnership to empower future leaders through educational and professional development initiatives.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-04
Description

MoU for large-scale plastic waste collection. HCB pledged to collect and recycle 540,000 kg of plastic waste within 2.5 years as part of commitment to collect equivalent of 100% of plastic waste generated by 2030. Project engages 10-25 collectors earning sustainable income.

4Sri Lanka College of Paediatricians
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-10
Description

Baby Cheramy and Sri Lanka College of Paediatricians partnership for child safety initiatives including Home Accidents Prevention Guide booklet launch.

hemas.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-08
Description

Partnership with Dialog Business Services and H.E.R Foundation to redefine period confidence across Sri Lanka through infrastructure support for menstrual health.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-23
Description

Partnership through Pink Changing Lives Program where Mary Kay and FLY & HELP Foundation with Hemas Holdings inaugurated the 11th Mary Kay preschool in Dankotuwa, Sri Lanka. Renovation funded at €42,000 converted unsafe building into safe learning facility for approximately 50 children aged 3 to 5.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-07-09
Description

Fems expanded Api Katha Karamu menstrual health program partnering with Red Cross, United Communities, and Ministries of Health and Education - Sri Lanka's largest menstrual health and hygiene education program.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-04-01
Description

Hemas Hospital Wattala entered cardiac care with Sri Lanka's most advanced technology in cardiac catheterization, providing state-of-the-art heart care services.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-28
Description

Hemas Pharmaceuticals partnered with Adopt an Ambulance initiative to support emergency medical services in Sri Lanka.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

MoU signed to extend Atlas SipSavi Scholarship Program for five years. Program addresses critical need where more than 20,000 children have discontinued education due to financial difficulties. Atlas provides educational materials and monthly allowances to selected children.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-06-05
Description

Hemas and Hatch partnership for Slingshot 2.0 accelerator program to propel Sri Lankan startups. Second iteration of successful accelerator supporting innovation and entrepreneurship.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

Partnership for Certificate Training Course in Diabetes Care - first of its kind in Sri Lanka. Addresses critical need for widespread expertise in diabetes management as disease prevalence outpaces specialist capacity. Inaugural batch had over 65 GPs completing the program.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries13 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hemas Holdings

Diversified Conglomerate (FMCG, Healthcare, Mobility)hemas.com

Hemas Holdings PLC is a publicly listed Sri Lankan conglomerate (CSE: HHL) operating across Consumer Brands (FMCG including Baby Cheramy, Clogard, Diva, Fems, Kumarika, Atlas), Healthcare (Morison pharmaceuticals, Hemas Hospitals), and Mobility (GSA for Emirates and Evergreen shipping), serving households, patients, and international principals across Sri Lanka and selected South Asian markets.

What Hemas Holdings does

Hemas Holdings PLC is a publicly listed Sri Lankan conglomerate (Colombo Stock Exchange ticker: HHL) operating across three core sectors: Consumer Brands, Healthcare, and Mobility. The Consumer Brands portfolio comprises 12+ sub-brands spanning baby care (Baby Cheramy, 1962), oral care (Clogard, 1992), laundry (Diva, 2003), feminine hygiene (Fems), hair care (Kumarika), men's grooming (Gold), beauty (Velvet, Vivya, Paris, Goya), and learning/stationery (Atlas, acquired 2018 and wholly owned since 2023). Manufacturing is concentrated at the Dankotuwa industrial complex and Homagama pharmaceutical plant, with proprietary consumer technologies including the Golden Trice Blend (heirloom rice skincare), Fit to Body (sanitary napkins), and Triple Action detergent stack.

The Healthcare segment covers pharmaceutical distribution and WHO-GMP compliant manufacturing through Morison Limited (70+ year heritage brands including Gripe Mixture, Lacto Calamine, Valmelix), plus Hemas Hospitals operating two state-of-the-art facilities in Wattala (with cardiac catheterization and mammography) and the newly opened Thalawathugoda site, holding ACHSI international accreditation. Revenue from this segment reached Rs. 33.6 billion in FY2024 H1 with Rs. 2.8 billion operating profit.

The Mobility segment acts as a captive channel partner and General Sales Agent representing international principals: Forbes Air Services has been Emirates' GSA in Sri Lanka for 30+ years managing 28 weekly flights, while Hemas Maritime/Evergreen Shipping Agency Lanka, Mazu Shipping, and FAR Shipping Agency (ISO 9001:2015) collectively service 17 container services and feeder routes across the Indian Subcontinent, Far East, and Bay of Bengal. Total H1 FY2024 group revenue was Rs. 54.4 billion with Rs. 5.0 billion operating profit; Hemas sells through a horizontally segmented model across traditional trade, modern trade, pharmacy, hospital, and GSA channels, with recent digital additions including the Fio period-tracking app, Hair Buddy e-commerce brand, and Baby Cheramy Diaper Helpdesk generative AI chatbot.

Hemas Holdings firmographics

Firmographics
Name
Hemas Holdings
Legal name
Hemas Holdings PLC
Website
https://hemas.com
Company type
Public
Founded year
1948
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Hemas Holdings PLC is a publicly listed Sri Lankan conglomerate (CSE: HHL) operating across Consumer Brands (FMCG including Baby Cheramy, Clogard, Diva, Fems, Kumarika, Atlas), Healthcare (Morison pharmaceuticals, Hemas Hospitals), and Mobility (GSA for Emirates and Evergreen shipping), serving households, patients, and international principals across Sri Lanka and selected South Asian markets.
Ownership category
akta.pro rank

Hemas Holdings industry classification

Industry
Product category
Diversified Conglomerate (FMCG, Healthcare, Mobility)
NAICS
General Warehousing and Storage (493110)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)
akta.pro secondary industry
Laundry & Textile Care Chemicals & Supplies Distribution (CRAOAGAI)

Keywords

  • FMCG manufacturing
  • Personal care products
  • Pharmaceutical distribution
  • Healthcare services
  • Logistics agency

Where Hemas Holdings is headquartered

Location

Headquarters

HQ city
Colombo
HQ country
Sri Lanka
HQ region
Asia

Offices11 records

Markets served

Hemas Holdings business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Consumer Brands: FMCG products including home care, personal care, feminine hygiene, baby care, oral care, hair care, and stationery/learning products. Revenue generated through sale of branded consumer goods across Sri Lanka and select international markets (Bangladesh, Nepal).
  2. Healthcare - Pharmaceuticals: Pharmaceutical distribution and manufacturing. Distribution business holds market-leading position. Manufacturing includes Morison branded OTC products and prescription medications. Sector reported Rs. 33.6 billion cumulative revenue with Rs. 2.8 billion operating profit.
  3. Healthcare - Hospitals: Private hospital services including inpatient admissions, outpatient volumes, and medical screenings. Hemas Hospitals includes facilities in Wattala and Thalawathugoda. Cardiac catheterization services added recently.
  4. Mobility - Aviation: Forbes Air Services operates as GSA for Emirates Airline for over 30 years. Supervises 28 weekly flights, managing passenger sales, cargo, pricing, retail services, and contact center operations.
  5. Mobility - Maritime: Evergreen Shipping Agency Lanka (6th largest container shipping line globally), Hemas Maritime, Mazu Shipping, and FAR Shipping Agency provide shipping agency services, logistics, and maritime solutions. Maritime sector experienced positive boost in volume and freight rates.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels5 records

Hemas Holdings product offering

Product offering

Core offering

Hemas Holdings PLC is a diversified Sri Lankan conglomerate that manufactures and distributes fast-moving consumer goods (FMCG) including baby care, personal care, oral care, feminine hygiene, hair care, and home care products under brands such as Baby Cheramy, Clogard, Diva, Fems, Kumarika, and Velvet. The group also operates Hemas Hospitals, distributes and manufactures pharmaceuticals through Hemas Pharmaceuticals and Morison Limited, and provides aviation and maritime logistics services as General Sales Agent (GSA) for Emirates Airline and as shipping agent for Evergreen Line and FAR Shipping.

Product overview

Hemas Holdings is a diversified Sri Lankan conglomerate operating three core business segments: Consumer Brands (home and personal care, baby care, beauty, oral care, hair care, feminine hygiene, pharmaceuticals, and learning/stationery products), Healthcare (hospitals, pharmaceutical distribution and manufacturing), and Mobility (maritime and aviation logistics). The Consumer Brands portfolio comprises multiple sub-brands including Baby Cheramy, Clogard, Dandex, Diva, Fems, Goya, Kumarika, Velvet, Vivya, Paris, Gold, Morison, and Atlas. Healthcare includes Hemas Hospitals, Hemas Pharmaceuticals, and Morison pharmaceutical manufacturing. Mobility operates through Forbes Air Services, Evergreen Shipping Agency, Far Shipping Agency, and Mazu Shipping.

Differentiator

Problem solved

Functional benefit

Brands

  • Baby Cheramy Peach Range: Original range of mild baby care products including soap, cream, cologne, shampoo and baby oil.
  • Baby Cheramy Floral Range
  • Baby Cheramy Herbal Range
  • Baby Cheramy Nil Manel Range
  • Velvet Body Lotion
  • Velvet Bodywash
  • Vivya Pure Glow Face Wash
  • Vivya Skin Recharge Serum
  • Vivya Advanced Radiance Day Cream
  • Vivya Intense Restore Night Cream
  • Morison Gripe Mixture
  • Morison Lacto Calamine
  • Morison Valmelix
  • Morison Baby Feeding Bottles
  • Morison Glucomile
  • Clogard Original Toothpaste
  • Clogard Natural Salt Toothpaste
  • Clogard Pancha Shakthi
  • Clogard Chooty
  • Diva Triple Action Detergent Powder
  • Diva Power Germ Guard
  • Diva Power Colour Guard
  • Diva PODS
  • Fems Aya
  • Fio
  • Kumarika Hair Oil
  • Kumarika Therapy Range
  • Velmetite Skin Care
  • Hemas Health Plus

Products and services

  • Baby Cheramy Sri Lanka's leading baby care brand with 60-year heritage, offering toiletries, accessories, and skincare products for infants including Peach, Floral, Herbal, and Nil Manel ranges.
  • Clogard Oral care brand offering toothpastes (Original, Natural Salt, Pancha Shakthi, Chooty for children), toothbrushes, and mouthwash for complete family dental care.
  • Diva Flagship laundry brand offering detergent powder with Triple Action technology (Stain Fighter, Perfume Boost, Optical Brightener), liquid detergent, PODS, and Power range products.
  • Fems Feminine hygiene brand offering sanitary napkins including Drytex Wings, Cotton Feel Wings, Superior Heavy Flow, and affordable Fems Aya line with Fit to Body technology.
  • Kumarika

Quantifiable outcome

  • Reduced water intensity by 11.8% to 1.5 m³ per rupee million in revenue
  • +4 more outcomes

Companies that use Hemas Holdings

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Hemas Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Hemas Holdings partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • Sisili Hanaro Encare (Encare)coreStrategic or Co-development Partner · 30 January 2026Service provider for safe collection and recycling of sanitary napkins under the Purple Bin Project. Encare manages Sri Lanka's largest centralized clinical waste management facility, approved by Central Environmental Authority. Collected sanitary napkins are recycled into eco-friendly bricks for sustainable building materials.
  • University of Sri Jayewardenepura (USJ)minorStrategic or Co-development Partner · 4 November 2025Hemas Consumer Brands and USJ forged landmark partnership to empower future leaders through educational and professional development initiatives.
  • Neptune RecyclerscoreStrategic or Co-development Partner · 4 November 2025MoU for large-scale plastic waste collection. HCB pledged to collect and recycle 540,000 kg of plastic waste within 2.5 years as part of commitment to collect equivalent of 100% of plastic waste generated by 2030. Project engages 10-25 collectors earning sustainable income.
  • Sri Lanka College of PaediatriciansminorStrategic or Co-development Partner · 10 October 2025Baby Cheramy and Sri Lanka College of Paediatricians partnership for child safety initiatives including Home Accidents Prevention Guide booklet launch.
  • Dialog Business ServicesminorStrategic or Co-development Partner · 8 October 2025Partnership with Dialog Business Services and H.E.R Foundation to redefine period confidence across Sri Lanka through infrastructure support for menstrual health.
  • Mary Kay Inc. / Reiner Meutsch FLY & HELP FoundationminorStrategic or Co-development Partner · 23 September 2025Partnership through Pink Changing Lives Program where Mary Kay and FLY & HELP Foundation with Hemas Holdings inaugurated the 11th Mary Kay preschool in Dankotuwa, Sri Lanka. Renovation funded at €42,000 converted unsafe building into safe learning facility for approximately 50 children aged 3 to 5.
  • Sri Lanka Red Cross SocietyminorStrategic or Co-development Partner · 9 July 2025Fems expanded Api Katha Karamu menstrual health program partnering with Red Cross, United Communities, and Ministries of Health and Education - Sri Lanka's largest menstrual health and hygiene education program.
  • Hemas Hospital Wattala / Cardiac Catheterization PartnerscoreTechnology or Integration · 1 April 2025Hemas Hospital Wattala entered cardiac care with Sri Lanka's most advanced technology in cardiac catheterization, providing state-of-the-art heart care services.
  • 1990 Suwa Seriya FoundationminorStrategic or Co-development Partner · 28 January 2025Hemas Pharmaceuticals partnered with Adopt an Ambulance initiative to support emergency medical services in Sri Lanka.
  • Department of Probation Child Care ServicescoreStrategic or Co-development Partner · 1 October 2024MoU signed to extend Atlas SipSavi Scholarship Program for five years. Program addresses critical need where more than 20,000 children have discontinued education due to financial difficulties. Atlas provides educational materials and monthly allowances to selected children.
  • Hatch (Slingshot Accelerator)minorStrategic or Co-development Partner · 5 June 2024Hemas and Hatch partnership for Slingshot 2.0 accelerator program to propel Sri Lankan startups. Second iteration of successful accelerator supporting innovation and entrepreneurship.
  • Sri Lanka College of Endocrinologists (SLCE)coreStrategic or Co-development Partner · 1 February 2024Partnership for Certificate Training Course in Diabetes Care - first of its kind in Sri Lanka. Addresses critical need for widespread expertise in diabetes management as disease prevalence outpaces specialist capacity. Inaugural batch had over 65 GPs completing the program.

Scale indicators15 records

Recent moves8 records

Expansion highlights7 records

Hemas Holdings competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

Hemas Holdings social profiles

Digital presence

Hemas Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hemas Holdings leadership team

Management profile

Number of profiles

Profiles7 records

Hemas Holdings subsidiaries and ownership

Company hierarchy

Subsidiaries13 records

Hemas Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hemas Holdings M&A and investment

M&A and investment

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hemas Holdings

What does Hemas Holdings do?

Hemas Holdings PLC is a diversified Sri Lankan conglomerate that manufactures and distributes fast-moving consumer goods (FMCG) including baby care, personal care, oral care, feminine hygiene, hair care, and home care products under brands such as Baby Cheramy, Clogard, Diva, Fems, Kumarika, and Velvet. The group also operates Hemas Hospitals, distributes and manufactures pharmaceuticals through Hemas Pharmaceuticals and Morison Limited, and provides aviation and maritime logistics services as General Sales Agent (GSA) for Emirates Airline and as shipping agent for Evergreen Line and FAR Shipping.

Is Hemas Holdings a public or private company?

Hemas Holdings is a public company. It is classified as public and is currently operating.

When was Hemas Holdings founded?

Hemas Holdings was founded in 1948. It employs 1,001 to 5,000 people.

Where is Hemas Holdings based?

Hemas Holdings is headquartered in Colombo, Sri Lanka, in the Asia region.

How does Hemas Holdings make money?

Five revenue lines are on record. Consumer Brands are the primary driver. The others are healthcare - Pharmaceuticals, healthcare - Hospitals, mobility - Aviation and mobility - Maritime.

Does Hemas Holdings have an API?

No public API is recorded for Hemas Holdings.

What industry is Hemas Holdings in?

Hemas Holdings's product category is Diversified Conglomerate (FMCG, Healthcare, Mobility). Its primary akta.pro industry code is TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant), with a secondary code of CRAOAGAI, Laundry & Textile Care Chemicals & Supplies Distribution. Its NAICS code is 493110 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestHemas Holdings 1Q operating profit 1.63M rupees vs. 2.06B rupees Y/YHemas Holdings PLC reported an operating profit of 1.63 billion rupees for the first quarter of the current fiscal year, a decline from 2.06 billion rupees in the same period last year, attributed to increased overheads and a one-off adverse impact from the National Medicines Regulatory Authority price reduction on distributor inventory. While the Consumer Brands sector demonstrated resilience with 17.1 percent cumulative revenue growth year-to-date and the Learning Segment posted 19.6 percent operating profit growth, broader economic challenges including inflationary pressures continue to constrain consumer spending.AInvestHemas Holdings 1Q revenue 28.8B rupees, +1.1% y/yHemas Holdings PLC reported revenue of 28.8 billion Sri Lankan rupees for the first quarter of FY2026/27, representing a year-over-year increase of 1.1%. The modest growth reflects ongoing macroeconomic challenges including inflation that rose to 5.4% in April 2026 and Sri Lankan rupee depreciation against the US dollar. Despite these headwinds, the Consumer Brands and Healthcare segments delivered solid performance, with Bangladesh operations growing 11% year-over-year, Morison achieving 18.6% volume growth, and Hemas Hospitals reporting 24% revenue growth for FY2025/26, while the company maintained a net cash position of 9.98 billion rupees.LankatalksHemas Sustains Q1 Revenue Amid Market Volatility; Sharpens Focus on Margin RecoveryHemas Group reported Q1 FY27 revenue of Rs. 28.77 billion, up 0.9% YoY, but EBITDA fell 14.1% to Rs. 2.26 billion and Group earnings declined 21.4% to Rs. 937 million as rapid cost escalation outpaced revenue growth. The earnings deterioration was primarily driven by heightened geopolitical uncertainty from the Middle East conflict, which sharply increased fuel, petroleum-based raw materials, freight, and insurance costs, with Sri Lankan petrol and diesel prices over 40% higher YoY and the LKR depreciating 8% on average. Hemas is implementing pricing actions and productivity initiatives to restore margins, with management targeting cost recovery and volume protection across Consumer Brands and Life Sciences while sustaining growth momentum in Hospitals and Mobility.LankatalksHemas Holdings Appoints Sabrina Esufally to the Board of DirectorsHemas Holdings PLC announced the appointment of Sabrina Esufally as an Executive Director to its Board, effective 1 July 2026. Esufally currently serves as Managing Director of Hemas Consumer Brands and has held leadership roles across pharmaceutical manufacturing, business development, innovation, and consumer brands since joining the Group in 2019. The appointment is intended to bring commercial leadership experience and a consumer perspective to support the Group's expansion into frontier markets and long-term strategic ambitions.LankatalksHemas Holdings Marks a Milestone Year: FY26 Delivers the Strongest Earnings for the GroupHemas Holdings reported record FY26 earnings of Rs 8.92B, up 10.7% YoY, with revenue of Rs 127.4B growing 8%. The group reinvested gains into operations, compressing EBITDA and EBIT margins by 40 and 50 basis points, while net profit margin and EPS expanded. Over USD 100M is earmarked for FY27-30 investments, including an acquisition to lift international revenue to 10%.HrnewsBeyond the Job Board: Why Sri Lanka’s Top Employers are Switching to AI-Powered WhatsApp RecruitmentXpressJobs launched Sri Lanka's first AI-powered recruitment assistant on WhatsApp, integrated with John Keells and BYD. The tool achieved a 98% open rate and 800 out of 1,000 candidates engaged in at least 10 exchanges. It also supports Sinhala and Tamil, enabling high-volume hiring for Daraz and Hemas.LankatalksSri Lanka stocks hold green trend during short weekSri Lanka's Colombo Stock Exchange closed midday Friday with the All Share Price Index up 0.65% to 22,735.61, while the S&P SL20 rose 0.51% to 6,262.75. Top gainers included Central Finance and Browns Investments, and Browns Beach Hotels announced a trading suspension from April 17 to 27.Business Wire IndiaPink Changing Lives®: Mary Kay Builds 11th Preschool in Sri Lanka, Turning a Dream Into Thousands of New BeginningsMary Kay Inc., through its Pink Changing Lives® Program in partnership with the Reiner Meutsch FLY & HELP Foundation and Hemas Holdings PLC, inaugurated the 11th Mary Kay preschool in Dankotuwa, Sri Lanka on September 23, 2025. The renovation, funded at €42,000, converted a structurally unsafe building into a safe learning facility serving approximately 50 children aged 3 to 5, with the Sri Lankan government committing to provide teachers and cover ongoing operational costs and having donated the land for construction.LankatalksHemas Group Delivers Strong First-Half Performance with 32.5% Growth in Earnings SUMMARY - Performance review for the Six Months ended 30th September 2025Hemas Group reported strong first-half FY2025 performance with cumulative earnings growing 32.5% to Rs. 3.3 billion, driven by revenue growth of 11.8% to Rs. 60.8 billion across all business sectors and sustained operating margins. The Group announced two landmark strategic investments including entering into an agreement to acquire a leading consumer products company in Kenya and commencing expansion of its Thalawathugoda hospital facility to become a tertiary healthcare institution. Hemas shares gained 110.6% year-on-year, significantly outperforming the CSE All Share Price Index and S&P SL20 Index during the period.Daily FTFirst Capital to host Mid-Year Outlook Investor Forum 2025First Capital Holdings PLC announced its Mid-Year Outlook Investor Forum 2025, scheduled for July 17, to provide investors with an analysis of Sri Lanka’s economic and investment prospects. The virtual event will feature research insights on key indicators and a panel discussion with executives from Access Engineering, Hemas Holdings PLC, and Advantis Bunkering. This year's forum will be conducted in Sinhala, Tamil, and English to ensure inclusivity across diverse investor groups.